Mycosis fungoides – Spot/plaque stage

LEGEND

Papillary dermal fibrosis is present.

  • In the patch or plaque stage, there is a perivascular and lichenoid infiltrate of atypical lymphocytes in the superficial and mid-dermis, with prominent epidermotropism.

  • The epidermis does not show a reactive response to this infiltrate — spongiosis is absent.

Mycosis fungoides – Patch-plaque stage

LEGEND

In the plaque stage, there may be acanthosis and elongation of rete ridges.

  • Pautrier microabscesses (collections of atypical lymphocytes within the epidermis) are observed.

  • Lymphocytes often appear haloed and display a linear arrangement along the basal membrane.

Mycosis fungoides – Patch-plaque stage – high magnification

LEGEND

  • Lymphocytes are highly atypical, with large, hyperchromatic nuclei.

Mycosis fungoides – Patch-plaque stage

CD3 is positive, highlighting the epidermotropism (the tendency of lymphocytes to invade the epidermis).

Mycosis fungoides – Tumor stage

LEGEND

In the tumor stage, the lymphocytic infiltrate extends through the entire dermis and may involve the subcutaneous tissue.

  • Epidermotropism and Pautrier microabscesses may still be observed but are less frequent than in the patch-plaque stage.

Mycosis fungoides – Tumor stage

LEGEND

  • Lymphocytes are atypical, very large (almost as large as keratinocytes), hyperchromatic, and irregular.

Mycosis fungoides

T-cell markers such as CD2, CD3, CD5, and CD7 are generally positive.

Here’s an example of a positive CD3

Mycosis fungoides

The B-cell marker CD20 is negative

Mycosis fungoides

There is often an increased proportion of CD4+ T-cells, with a CD4:CD8 ratio > 3:1.

CD4 expression is positive, as shown in the example.

Mycosis fungoides

There can be loss of expression of certain T-cell markers, particularly CD7 or CD5.

This sample demonstrates reduced CD7 expression compared to CD3.